7Circumstances in which designated vaccines may be provided — particular vaccines

7 Circumstances in which designated vaccines may be provided — particular vaccines

(1A) For item 108A of Schedule 1, the following number of doses and booster doses of a designated vaccine mentioned in that item may be provided to a person who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; a person who has complement deficiency or a person undergoing eculizumab treatment:

(a) Primary doses according to the following number of doses:

(i) if aged 6 weeks to 5 months at the start of their vaccine course – 4 doses;

(ii) if aged 6 to 11 months at the start of their vaccine course – 3 doses; or

(iii) if aged 12 months or older at the start of their vaccine course – 2 doses;

(b) plus booster doses according to the following number and timing of doses:

(iv) if they completed their primary schedule at less than or equal to 6 years of age ‑ 1 booster dose 3 years after completing the primary schedule, and then 1 booster dose every 5 years after that; or

(v) if they completed their primary schedule at 7 years of age or older ‑ 1 booster dose every 5 years after completing the primary schedule.

(1B) For item 108C of Schedule 1, the following number of doses and booster doses of a designated vaccine mentioned in that item may be provided to a person who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; a person who has complement deficiency or a person undergoing eculizumab treatment:

(a) primary doses according to the following number of doses:

(i) if aged 12 months old or older at the start of their vaccine course – 2 doses;

(b) plus booster doses according to the following number and timing of doses:

(i) if they completed their primary doses at less than or equal to 6 years of age ‑ 1 booster dose 3 years after completing the primary doses, and then 1 booster dose every 5 years after that; or

(ii) if they completed their primary doses at 7 years of age or older ‑ 1 booster dose every 5 years after completing the primary doses.

(1C) For item 111B of Schedule 1, the circumstances are that a designated vaccine referred to in that item may be provided to:

(a) a child who is about 6 months old and is an Aboriginal person or Torres Strait Islander; or

(b) a child who is about 6 months old and has one or more of the following medical risk conditions:

(i) functional or anatomical asplenia, including sickle cell disease, other haemoglobinopathies, congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; or

(ii) immunocompromising conditions, including congenital or acquired immune deficiency including symptomatic IgG subclass or isolated IgA deficiency, haematological malignancies, solid organ transplant, haematopoietic stem cell transplant or HIV infection; or